Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Lorraine Blaise"'
Autor:
Raffaele Brustia, Mohamed Bouattour, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, Valérie Vilgrain, Edouard Larrey, Chetana Lim, Olivier Scatton, Sanaa El Mouhadi, Violaine Ozenne, François Paye, Pierre Balladur, Anthony Dohan, Pierre-Philippe Massault, Stanislas Pol, Marco Dioguardi Burgio, Ailton Sepulveda, Francois Cauchy, Alain Luciani, Daniele Sommacale, Vincent Leroy, Julien Calderaro, Francoise Roudot-Thoraval, Jean-Charles Nault, Giuliana Amaddeo
Publikováno v:
Annals of Hepatology, Vol 28, Iss 6, Pp 101141- (2023)
Introduction and Objectives: The lockdown policy introduced in 2020 to minimize the spread of the COVID-19 pandemic, significantly affected the management and care of patients affected by hepatocellular carcinoma (HCC). The aim of this follow-up stud
Externí odkaz:
https://doaj.org/article/8f6ec44b4e9548788bba1e30c48fda30
Autor:
Elia Gigante, Yohann Haddad, Jean-Charles Nault, Olivier Sutter, Einas Abou Ali, Baptiste Bonnet, Gisèle N’Kontchou, Veronique Grando, Nathalie Ganne-Carrié, Pierre Nahon, Lorraine Blaise, Julien Calderaro, Nathalie Barget, Olivier Seror, Marianne Ziol
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Aggressive intrasegmental recurrence (AIR) is a form of local recurrence associated with a dismal prognosis and defined by multiple nodules or by an infiltrative mass with a tumor thrombus, occurring in the treated segment, after radiofreque
Externí odkaz:
https://doaj.org/article/57958147835b477c899deeba32866b29
Autor:
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, Bruno Sangro, Jordi Bruix, Marco Sanduzzi-Zamparelli, Wacław Hołówko, Mohamed El Kassas, Tudor Mocan, Mohamed Bouattour, Philippe Merle, Frederik J.H. Hoogwater, Saleh A. Alqahtani, Helen L. Reeves, David J. Pinato, Emmanouil Giorgakis, Tim Meyer, Gerda Elisabeth Villadsen, Henning Wege, Massimiliano Salati, Beatriz Mínguez, Giovan Giuseppe Di Costanzo, Christoph Roderburg, Frank Tacke, María Varela, Peter R. Galle, Mario Reis Alvares-da-Silva, Jörg Trojan, John Bridgewater, Giuseppe Cabibbo, Christian Toso, Anja Lachenmayer, Andrea Casadei-Gardini, Hidenori Toyoda, Tom Lüdde, Rosanna Villani, Ana María Matilla Peña, Cassia Regina Guedes Leal, Monica Ronzoni, Manuel Delgado, Christie Perelló, Sonia Pascual, José Luis Lledó, Josepmaria Argemi, Bristi Basu, Leonardo da Fonseca, Juan Acevedo, Alexander R. Siebenhüner, Chiara Braconi, Brandon M. Meyers, Alessandro Granito, Margarita Sala, Carlos Rodríguez-Lope, Lorraine Blaise, Manuel Romero-Gómez, Federico Piñero, Dhanny Gomez, Vivianne Mello, Rogerio Camargo Pinheiro Alves, Alex França, Fernanda Branco, Giovanni Brandi, Gustavo Pereira, Susanna Coll, Maria Guarino, Carlos Benítez, Maria Margarita Anders, Juan C. Bandi, Mercedes Vergara, Mariona Calvo, Markus Peck-Radosavljevic, Ignacio García-Juárez, Vincenzo Cardinale, Mar Lozano, Martina Gambato, Stefano Okolicsanyi, Dalia Morales-Arraez, Alessandra Elvevi, Alberto E. Muñoz, Alberto Lué, Massimo Iavarone, Maria Reig
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100260- (2021)
Background & Aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening o
Externí odkaz:
https://doaj.org/article/358015dbb4fa490089fab9515bd56c57
Autor:
Giuliana Amaddeo, Raffaele Brustia, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, Olivier Séror, Edouard Larrey, Chetana Lim, Olivier Scatton, Sanaa El Mouhadi, Violaine Ozenne, François Paye, Pierre Balladur, Anthony Dohan, Pierre-Philippe Massault, Stanislas Pol, Marco Dioguardi Burgio, Valérie Vilgrain, Ailton Sepulveda, Francois Cauchy, Alain Luciani, Daniele Sommacale, Vincent Leroy, Francoise Roudot-Thoraval, Mohamed Bouattour, Jean-Charles Nault
Publikováno v:
JHEP Reports, Vol 3, Iss 1, Pp 100199- (2021)
Background & Aims: Patients affected by hepatocellular carcinoma (HCC) represent a vulnerable population during the COVID-19 pandemic and may suffer from altered allocation of healthcare resources. The aim of this study was to determine the impact of
Externí odkaz:
https://doaj.org/article/2a89085a590e4823b55104b81a75c3a6
Autor:
Philippe Rochigneux, Jean-Charles Nault, Françoise Mallet, Anne-Sophie Chretien, Nathalie Barget, Alejandro J. Garcia, Lucie Del Pozo, Valérie Bourcier, Lorraine Blaise, Véronique Grando-Lemaire, Gisèle N’Kontchou, Pierre Nahon, Olivier Seror, Marianne Ziol, Nathalie Ganne-Carrié, Daniel Olive
Publikováno v:
OncoImmunology, Vol 8, Iss 8 (2019)
Background: Percutaneous radiofrequency ablation (RFA) is one of the main treatments of small hepatocellular carcinoma (HCC). However, it remains unclear whether this local treatment can induce systemic immune variations. Methods: We conducted a pros
Externí odkaz:
https://doaj.org/article/51277d19381545e1be3a3045ef347872
Autor:
Gaël S. Roth, Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Mélodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrié, Lorraine Blaise, Olivier Sutter, Thomas Decaens, Jean-Charles Nault
Publikováno v:
Cancers, Vol 13, Iss 4, p 812 (2021)
No definitive conclusion could be reached about the role of chemotherapy in adjunction of embolization in the treatment of hepatocellular carcinoma (HCC). We aim to compare radiological response, toxicity and long-term outcomes of patients with hepat
Externí odkaz:
https://doaj.org/article/4c49494ab66545de8809018044211c70
Autor:
Edouard Larrey, Bertille Campion, Manon Evain, Philippe Sultanik, Lorraine Blaise, Héloïse Giudicelli, Mathilde Wagner, Philippe Cluzel, Marika Rudler, Nathalie Ganne‐Carrié, Dominique Thabut, Manon Allaire
Publikováno v:
Liver International. 42:2843-2854
Atezolizumab-bevacizumab is the new standard for advanced hepatocellular carcinoma (HCC) but its impact on portal hypertension (PHT) is unknown. We aimed to identify predictive factors of acute variceal bleeding (AVB) and to monitor PHT parameters un
Autor:
Gael, Roth, Yann, Teyssier, Maxime, Benhamou, Mélodie, Abousalihac, Stefano, Caruso, Christian, Sengel, Olivier, Seror, Julien, Ghelfi, Arnaud, Seigneurin, Nathalie, Ganne-Carrie, Elia, Gigante, Lorraine, Blaise, Olivier, Sutter, Thomas, Decaens, Jean-Charles, Nault
Publikováno v:
World Journal of Gastroenterology. 28:5324-5337
At the diagnosis of hepatocellular carcinoma (HCC), more than 90% of HCC patients present cirrhosis, a clinical condition often associated to malnutrition. Sarcopenia is an indirect marker of malnutrition assessable on computed tomography (CT).To eva
Autor:
Nesrine Mouhoubi, Jessica Bamba-Funck, Angela Sutton, Lorraine Blaise, Olivier Seror, Nathalie Ganne-Carrié, Marianne Ziol, Gisèle N'Kontchou, Nathalie Charnaux, Pierre Nahon, Jean-Charles Nault, Erwan Guyot
Publikováno v:
Journal of Hepatocellular Carcinoma.
Nesrine Mouhoubi,1 Jessica Bamba-Funck,1,2 Angela Sutton,1,2 Lorraine Blaise,3 Olivier Seror,4 Nathalie Ganne-Carrié,3,5 Marianne Ziol,6,7 Gisèle NâKontchou,3 Nathalie Charnaux,1,2 Pierre Nahon,3,5 Jean-Charles Nault,3,5,* Erwan Guyot1
Autor:
Claudia Campani, Jessica Bamba‐Funck, Bertille Campion, Sabrina Sidali, Lorraine Blaise, Nathalie Ganne‐Carrié, Alix Demory, Olivier Sutter, Edouard Larrey, Manon Evain, Haroun Ghannouchi, Mathilde Wagner, Fabio Marra, Angela Sutton, Manon Allaire, Jean‐Charles Nault
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES.
The combination of atezolizumab and bevacizumab (AtezoBev) is the current first-line treatment for patients with hepatocellular carcinoma (HCC). Our aim was to evaluate the prognostic role of alpha-foetoprotein (AFP) early response and its combinatio